dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Terviseamet
Sissetulev dokumentAvalik

Edastuskiri

Terviseamet · 14. märts 2025
Viit
8-2/25/1927-1
Registreeritud
14. märts 2025
Dokumendi liik
Sissetulev dokument
Adressaat
ECDC Microbiology
Saabumis/saatmisviis
e-post
Funktsioon
8 Nakkushaiguste seire, ennetuse ja tõrje korraldamine
Sari
8-2 Nakkushaiguste epidemioloogiaalane riigiväline kirjavahetus
Toimik
8-2/2025
Vastutaja
Kärt Sõber (TA, Peadirektori asetäitja (1) vastutusvaldkond, Nakkushaiguste epidemioloogia osakond)

Failid

  • 📎E-kiri.eml51 KB

Sisu (failidest)

Saatja: "ECDC Microbiology" <[email protected]> Saaja: "Indra Alexander" <[email protected]>, "Apfalter Petra" <[email protected]>, "Wesley.Mattheus" <[email protected]>, "steven.vangucht" <[email protected]>, "ivanoov" <[email protected]>, "stefka.krumova" <[email protected]>, "ljiljana.zmak" <[email protected]>, "selma.bosnjak" <[email protected]>, "Ivana Ferenčak" <[email protected]>, "m.mendris" <[email protected]>, "Fani Theophanous" <[email protected]>, "dpieridou" <[email protected]>, "ckaragiannis" <[email protected]>, "Zuzana Okonji" <[email protected]>, "pavla.krizova" <[email protected]>, "Kristina Træholt Franck" <[email protected]>, "Eva Møller Nielsen" <[email protected]>, "Liisi Kink" <[email protected]>, "Salmenlinna Saara" <[email protected]>, "Savolainen-Kopra Carita" <[email protected]>, "Mathieu TOURDJMAN" <[email protected]>, "CASTRO-ALVAREZ Javier" <[email protected]>, "mankertza" <[email protected]>, "WernerG" <[email protected]>, "Ιωάννα Σπηλιοπούλου" <[email protected]>, [email protected], "Judit Henczkó" <[email protected]>, "Kristjan Orri Helgason" <[email protected]>, "Hannes Bjarki Vigfússon" <[email protected]>, "Kirsten Schaffer" <[email protected]>, "ARHAI HPSC" <[email protected]>, "annateresa.palamara" <[email protected]>, "Stefanelli Paola" <[email protected]>, "gatis.pakarna" <[email protected]>, "Walser-Domjan Esther" <[email protected]>, "Visscher Carla" <[email protected]>, "svajune.muralyte" <[email protected]>, "Jonas Žvirgždas" <[email protected]>, "Trung Nguyen" <[email protected]>, "claire.marantidis-cordina" <[email protected]>, "christopher.barbara" <[email protected]>, "Wanda Han" <[email protected]>, "Chantal Reusken" <[email protected]>, "Trine Marie LAbée-Lund Normann" <[email protected]>, "Christine Genevieve Monceyron Jonassen" <[email protected]>, "Karoline Bragstad" <[email protected]>, "Gierczyński Rafał" <[email protected]>, "a.skoczynska" <[email protected]>, "Helena Cortes Martins" <[email protected]>, "Jorge Machado" <[email protected]>, "Raluca Gatej" <[email protected]>, "teodora.vremera" <[email protected]>, "edita.staronova" <[email protected]>, "lucia.madarova" <[email protected]>, "Tjaša Žohar Čretnik" <[email protected]>, "Andrej Steyer" <[email protected]>, "katarina.prosenc" <[email protected]>, "ijado" <[email protected]>, "Horacio Gil Gil" <[email protected]>, "sara.byfors" <[email protected]>, "Andreas.Brave" <[email protected]> Teema: Shipment of physical specimens Kuupäev: 2025-03-14 10:45 Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. To: National Focal Points for Microbiology (members/alternates) cc. National Coordinators (members/alternates) Dear National Focal Points for Microbiology, From our work with the EURLs and the disease networks, ECDC has received information on recent challenges related to shipment of physical specimens. This seems to primarily be related to clinical specimens, but we are of course also interested in learning if this also affects shipments of other materials, e.g. isolates, RNA or DNA samples, cell lines and synthetic controls. We would therefore appreciate your feedback on the questions below for us to fully understand the extent of the issues. 1. Are you currently or can you foresee to be experiencing restrictions for shipping (a) clinical specimens, (b) isolates, (c) RNA or DNA samples, (d) cell lines or (e) synthetic controls to other countries? If yes, please provide details in the replies to the questions below: 2. What is the nature of these restrictions? 3. Are the restrictions limited to shipments outside of the EU/EEA, or do they also affect shipments within the EU/EEA? 4. What are the legal or policy basis for the restrictions, and who is enforcing them? 5. What measures are you taking (or discussing / planning on taking) at the national level to address these restrictions? Thank you in advance for providing your feedback on this no later than Friday 28 March 2025, and please do let us know should you have any related questions or queries. Kind regards, Daniel Palm on behalf of the ECDC Microbiology Team European Centre for Disease Prevention and Control (ECDC)Gustav III:s boulevard 40, 169 73 Solna, Sweden Phone +46 (0)8 58 60 10 00 <https://www.ecdc.europa.eu/> www.ecdc.europa.eu Follow ECDC on: <http://www.facebook.com/ECDC.EU> <https://bsky.app/profile/ecdc.europa.eu> <http://www.linkedin.com/company/ecdc> <http://www.youtube.com/user/ECDCchannel> <https://www.instagram.com/ecdc.eu> <https://www.threads.net/@ecdc.eu> Confidentiality Notice If you are not the intended recipient of this message, you are hereby kindly requested, to, consecutively, refrain from disclosing its content to any third party, delete it and inform its sender of the erroneous transmittal. Classified as ECDC NORMAL
Allikas: Terviseamet dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel